Clinical Trial

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 23, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This study seeks to explore changes in the neural pathways and arm function following a breathing intervention in the multiple sclerosis (MS) population. The breathing intervention, known as Acute Intermittent Hypoxia (AIH), involves breathing brief bouts of low levels of oxygen. Research has found AIH to be a safe and effective intervention resulting in increased ankle strength in people with MS. Here, the study examines arm and hand function before and after AIH. In order to better understand the brain and spinal cord response to AIH, the investigators will measure muscle response, and signals sent from the brain to the arm muscles before and after AIH.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-25.
Status change: Not Yet Recruiting → Recruiting 2026-02-19
Trial Details
NCT Number NCT06390930
Lead Sponsor Shirley Ryan AbilityLab
Collaborators: National Multiple Sclerosis Society
Conditions Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive
Enrollment 22 participants
Start Date 2025-02-01
Primary Completion 2026-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-02-23